Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Inventory (2018 - 2026)

TransMedics has reported Inventory over the past 8 years, most recently at $48.9 million for Q4 2025.

  • For Q4 2025, Inventory rose 5.0% year-over-year to $48.9 million; the TTM value through Dec 2025 reached $48.9 million, up 5.0%, while the annual FY2025 figure was $48.9 million, 5.0% up from the prior year.
  • Inventory for Q4 2025 was $48.9 million at TransMedics, up from $44.5 million in the prior quarter.
  • Over five years, Inventory peaked at $52.2 million in Q3 2024 and troughed at $11.8 million in Q1 2021.
  • A 5-year average of $31.9 million and a median of $34.7 million in 2023 define the central range for Inventory.
  • Biggest five-year swings in Inventory: surged 114.68% in 2023 and later decreased 20.14% in 2025.
  • Year by year, Inventory stood at $14.9 million in 2021, then skyrocketed by 38.67% to $20.6 million in 2022, then surged by 114.68% to $44.2 million in 2023, then rose by 5.24% to $46.6 million in 2024, then rose by 5.0% to $48.9 million in 2025.
  • Business Quant data shows Inventory for TMDX at $48.9 million in Q4 2025, $44.5 million in Q3 2025, and $38.9 million in Q2 2025.